Olympus, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, will demonstrate for the first time in the U.S. its new OLYSENSE^™ Platform with the CADDIE^™ computer-aided detection device at the Digestive Disease Week (DDW) annual meeting May 4-6 in San Diego.

The OLYSENSE Platform with the CADDIE device uses cloud-based artificial intelligence (AI) technology to aid the gastroenterologist in suspected polyp detection during a colonoscopy. 

"We are very excited to be bringing our CADe AI solution to the U.S. market as part of the visionary OLYSENSE^™ Platform, and we're thrilled to be demonstrating the first cloud-based AI for colonoscopy solution during DDW," said Miquel Àngel Garcìa, Senior Vice President and General Manager for Endoscopy Ecosystem Solutions at Olympus Corporation. "As a global MedTech leader in endoscopy, we are committed to offering gastroenterologists the best solutions possible along the entire patient care pathway. We look forward to a very robust and comprehensive program of product demonstrations and physician talks at this year's DDW meeting."

The OLYSENSE Platform with the CADDIE device is part of a total portfolio of ADR solutions and technologies that will be featured during DDW. These include visualization technologies such as the ENDOCUFF Vision^™ device and Texture and Color Enhancement Imaging (TXI^™) technology used in the treatment of GI diseases and disorders.

Also featured during DDW will be the Olympus^® portfolio of hemostasis products, ERCP portfolio products, and the newly launched EU-ME3 ultrasound processor.

Hemostasis Portfolio at DDW 
Hemostatis products are used by physicians performing advanced endoluminal procedures such as endoscopic submucosal dissection (ESD), endoscopic mucosal resection (EMR) and peroral endoscopic myotomy (POEM). The Olympus^® products that will be discussed and demonstrated during DDW include: Red Dichromatic Imaging (RDI^™) technology for identifying the source of bleeds, which is part of the EVIS X1^™ endoscopy system; Endoclot® PHS hemostatic powder; and the Retentia^™ HemoClip.

New for Endoscopic Ultrasound 
The EU-ME3 is a compact ultrasound processor for use with Olympus^® endoscopic and endobronchial ultrasound (EUS and EBUS) equipment that has been designed for integration with conventional endoscopy on a single workstation. With its high-resolution imaging and a display that promotes clear visualization, the EU-ME3 ultrasound processor supports detection and characterization of lesions. Advanced features such as Contrast Harmonic Echo (CHE) and Shear Wave Quantification (SWQ) help to explore the future of endosonography.

Physician Talks at Olympus Booth #5129 

• Dr. Nikhil Kumta from NYU Langone Health will review the Olympus tools and technology for third space endoscopy, which are procedures such as endoscopic submucosal dissection and endoscopic mucosal resection. This talk takes place Sunday, May 4^th at 11 a.m.
• Leading ADR experts Dr. Doug Rex from Indiana University Health and Dr. Cesare Hassan from Nuovo Regina Margherita Hospital in Rome, Italy, will talk about leveraging technology to enhance adenoma detection on Sunday, May 4^th at 1 p.m.
• Dr. Jason Samarasena from UCI (University of California Irvine) Health will present on Olympus innovations and devices for advanced third-space endoscopy, such as peroral endoscopy myotomy (POEM), on Monday, May 5^th at 11 a.m. 

In partnership with ASGE, Olympus is sponsoring a number of educational opportunities for physicians interested in learning more about improving ADR with Olympus solutions and controlling bleeds during endoscopic procedures. Additionally, Dr. Dennis Yang from Advent Health Medical Group will lead an ASGE Endo Theater Presentation on the utility of image-enhanced endoscopy during endoscopic resection on Monday, May 5^th at 1-1:45 p.m. 

Drs. Kumta, Rex, Hassan, Samarasena, and Yang are paid consultants to Olympus Corporation, its subsidiaries and/or its affiliates.